Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 09.06.2025 1 Am J Ophthalmol 7 BMC Cancer 3 Br J Dermatol 4 Cancer 2 Cancer Lett 3 Clin Exp Dermatol 2 Int J Cancer 10 Int J Dermatol 2 Intern Med 10 J Cutan Pathol 2 J Dermatol 6 J Invest Dermatol 1 Lancet 2 Mycoses 2 N Engl J Med 15 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Ophthalmol

1. CHOU HD, Heimann H, Damato BE, Hussain RN, et al
   Inadvertent Scleral Perforation During Choroidal Melanoma Surgeries: Incidence, Risk Factors, Management, and Outcomes: Scleral Perforation in Melanoma Surgery.
   Am J Ophthalmol. 2025 May 31:S0002-9394(25)00278.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. EBRAHIM NAA, Hussein MA, Sobeih ME, Amin NH, et al
   From biomarker to targeted therapy: investigating trophoblast cell-surface antigen 2 expression in triple-negative breast cancer- insights from the national cancer institute.
   BMC Cancer. 2025;25:1008.
   PubMed         Abstract available
   
   
3. EL-JAMMAL M, Saifi O, Bazan J, Zeidan YH, et al
   Radiation therapy in clinically node positive HER2 positive breast cancer after primary systemic therapy and breast conserving surgery: pooled analysis of TRYPHAENA and NeoSphere trials.
   BMC Cancer. 2025;25:996.
   PubMed         Abstract available
   
   
4. KARIMI MA, Khadem R, Haraj A, Farahani MA, et al
   The impact of sodium-glucose cotransporter-2 inhibitors on breast cancer and cancer-related mortality: a systematic review and meta-analysis of randomized controlled trials.
   BMC Cancer. 2025;25:991.
   PubMed         Abstract available
   
   
5. OSBORNE A, Adnani QES, Ahinkorah BO
   Breast cancer incidence in Indonesia: a sex-disaggregated analysis using WHO health equity assessment toolkit data.
   BMC Cancer. 2025;25:986.
   PubMed         Abstract available
   
   
6. LIANG Y, Xu H, Lin J, Tang W, et al
   Multi-modal radiomics model based on four imaging modalities for predicting pathological complete response to neoadjuvant treatment in breast cancer.
   BMC Cancer. 2025;25:985.
   PubMed         Abstract available
   
   
7. BREEK K, Abuhalima D, Salameh H, Al-Jabi SW, et al
   Self-reported side effects of breast cancer treatment and its impact on quality of life: a multicenter cross-sectional study in a low- and middle-income country.
   BMC Cancer. 2025;25:975.
   PubMed         Abstract available
   
   
8. AL-MATRAFI AR, Bedair KF, Srinivasan S, Palmer C, et al
   Clinical and pharmacogenomic predictors of survival in tamoxifen treated breast cancer female patients: a real-world study.
   BMC Cancer. 2025;25:974.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

9. DANESH K, Adler BL, Vecerek N
   Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus.
   Br J Dermatol. 2025 Jun 3:ljaf215. doi: 10.1093.
   PubMed        
   
   
10. LIU X, McBride JD
    Unmethylated PRAME DNA in Tissue and Plasma: A Promising Marker for Melanoma.
    Br J Dermatol. 2025 Jun 3:ljaf217. doi: 10.1093.
    PubMed        
    
    
11. LIU Z, Zhang Y, Wang K, Xie F, et al
    Early diagnosis model of mycosis fungoides and five inflammatory skin diseases based on multi-modal data-based convolutional neural network.
    Br J Dermatol. 2025 Jun 4:ljaf212. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer

12. FUMAGALLI IA, Warner ET, Llanos AAM, Quesenberry CP, et al
    Racial and ethnic variation in body composition and prognosis of nonmetastatic breast cancer.
    Cancer. 2025;131:e35926.
    PubMed         Abstract available
    
    
13. AUBUCHON KE, Galvan CJC, Duron Y, Sampayo I, et al
    Randomized trial of a community-based, culturally tailored intervention: High engagement among Latina breast cancer survivors.
    Cancer. 2025;131:e35842.
    PubMed         Abstract available
    
    
14. TRINCONI CUNHA M, Wallace N, Porceddu S, Ferrarotto R, et al
    Top advances of the year: Developments of immunotherapy in cutaneous squamous cell carcinoma, 2023-2024.
    Cancer. 2025;131:e35920.
    PubMed         Abstract available
    
    
15. NIERENGARTEN MB
    New standard of care for patients with asymptomatic brain metastases from melanoma.
    Cancer. 2025;131:e35885.
    PubMed        
    
    

    
    Cancer Lett

16. ELAYAPILLAI SP, Dogra S, Hladik C, Lausen J, et al
    Preferential Release of microRNAs via Extracellular Vesicles is Associated with Ductal Carcinoma In Situ to Invasive Breast Cancer Progression.
    Cancer Lett. 2025 May 17:217794. doi: 10.1016/j.canlet.2025.217794.
    PubMed         Abstract available
    
    
17. LIU S, Chen H, Gagea M, Federico L, et al
    ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy.
    Cancer Lett. 2025 May 6:217775. doi: 10.1016/j.canlet.2025.217775.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

18. SKAYEM C, Richard MA, Saint Aroman M, Merhand S, et al
    Epidemiology of atopic dermatitis: a global worldwide study.
    Clin Exp Dermatol. 2025 May 31:llaf233. doi: 10.1093.
    PubMed        
    
    
19. GUNER ME, Kurutas EB, Ozturk P
    Serum Raftlin and 8-isoprostoglandin F2alpha as Potential Biomarkers in Seborrheic Dermatitis: A Case-Control Study.
    Clin Exp Dermatol. 2025 May 31:llaf243. doi: 10.1093.
    PubMed         Abstract available
    
    
20. 
    Correction to: Assessing the 5-year persistence in positive clinical response with innovative psoriasis treatments: a network meta-analysis of Psoriasis Area and Severity Index score.
    Clin Exp Dermatol. 2025 Jun 2:llaf231. doi: 10.1093.
    PubMed        
    
    

    
    Int J Cancer

21. SCHMIDT ME, Hiensch AE, Depenbusch J, Monninkhof EM, et al
    Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial.
    Int J Cancer. 2025 Apr 3. doi: 10.1002/ijc.35429.
    PubMed         Abstract available
    
    
22. LAI X, Luan C, Zhang Z, Wessely A, et al
    SOX10, MITF, and microRNAs: Decoding their interplay in regulating melanoma plasticity.
    Int J Cancer. 2025 Jun 3. doi: 10.1002/ijc.35499.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

23. ZHANG J, Liu S, Guo W, Huang Y, et al
    The Efficacy and Safety of 1% Oxyresveratrol for Treating Facial Melasma on Sensitive Skin in Women: A Double-Blind Placebo-Controlled Trial.
    Int J Dermatol. 2025 Jun 1. doi: 10.1111/ijd.17882.
    PubMed        
    
    
24. HUANG S, Cernova J, Mabayoje D, Godbole G, et al
    Disseminated Toxoplasmosis Presenting With Panniculitis in a Renal Transplant Recipient.
    Int J Dermatol. 2025 Jun 1. doi: 10.1111/ijd.17881.
    PubMed        
    
    
25. TASHIMA LM, Gramann AK, Lopes AVV, Rastelli GJC, et al
    Prevalence of Symptoms in Basal Cell Carcinoma and Their Correlation With Clinical and Histological Features.
    Int J Dermatol. 2025 Jun 1. doi: 10.1111/ijd.17877.
    PubMed        
    
    
26. TRAN TS, Piche SL, Wetter DA, Nguyen GH, et al
    Biologic Therapies for Managing Cutaneous Immune-Related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors.
    Int J Dermatol. 2025 Jun 4. doi: 10.1111/ijd.17894.
    PubMed        
    
    
27. KOUMPRENTZIOTIS IA, Stefanaki I, Rompoti N, Vavouli C, et al
    Guselkumab Is Effective for the Management of Scalp Psoriasis in Both Biologic-Naive and Biologic-Experienced Patients: Results From a Real-World, Retrospective Study.
    Int J Dermatol. 2025 Jun 4. doi: 10.1111/ijd.17889.
    PubMed        
    
    
28. JIMENEZ-SANCHEZ A, Munoz Moreno-Arrones O, Bea-Ardebol S, Mayo-Martinez F, et al
    Response to Sonidegib in Advanced Basal Cell Carcinomas by Histological Subtype: A Real-World Cohort.
    Int J Dermatol. 2025 Jun 4. doi: 10.1111/ijd.17896.
    PubMed        
    
    
29. NIHAL A, Yang K, Pavlidakey PG
    OpenEvidence Is Superior to GPT in Skin Cancer Guideline Queries.
    Int J Dermatol. 2025 Jun 5. doi: 10.1111/ijd.17893.
    PubMed        
    
    
30. VESTERGAARD C, Torrelo A, Christen-Zaech S
    Clinical Benefits of Basic Emollient Therapy for the Management of Patients With Xerosis Cutis.
    Int J Dermatol. 2025;64 Suppl 1.
    PubMed         Abstract available
    
    
31. AUGUSTIN M, Brignone M
    Optimization of Basic Emollient Therapy for the Management of Xerosis Cutis.
    Int J Dermatol. 2025;64 Suppl 1.
    PubMed         Abstract available
    
    
32. SZEPIETOWSKI JC, Tadini G
    Basic Emollients for Xerosis Cutis Not Associated With Atopic Dermatitis: A Review of Clinical Studies.
    Int J Dermatol. 2025;64 Suppl 1:29-46.
    PubMed         Abstract available
    
    

    
    Intern Med

33. NISHIMURA N, Kawano S, Tamae A, Yoshizawa S, et al
    Garcin Syndrome in a Patient with Hypertrophic Pachymeningitis Following Otitis Media with Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis (OMAAV).
    Intern Med. 2025;64:1756-1760.
    PubMed         Abstract available
    
    
34. HIRAMATSU M, Inoue M, Seishima M, Yamamoto J, et al
    Psoriasis Vulgaris on Hemodialysis Patient's Arteriovenous Fistula.
    Intern Med. 2025 Jun 5. doi: 10.2169/internalmedicine.5768.
    PubMed        
    
    

    
    J Cutan Pathol

35. BEATSON ME, Smithy JW, Domenico D, Gundem G, et al
    Malignant CRTC1::TRIM11 Cutaneous Tumor With Lethal Outcome: Histopathologic and Molecular Findings.
    J Cutan Pathol. 2025 Jun 2. doi: 10.1111/cup.14824.
    PubMed         Abstract available
    
    
36. NAGARKAR A, Turbeville J, Hinshaw MA, LeBoit PE, et al
    Large Congenital Melanocytic Nevus With LMNA::NTRK1 Fusion: Expanding Targeted Therapy Options for Congenital Nevi and Melanoma.
    J Cutan Pathol. 2025 Jun 3. doi: 10.1111/cup.14822.
    PubMed         Abstract available
    
    
37. VADALI MV, Gener MA, Fraga GR
    Histochemistry Testing for Cutaneous Fungal Infections: A Meta-Analysis.
    J Cutan Pathol. 2025 Jun 4. doi: 10.1111/cup.14826.
    PubMed         Abstract available
    
    
38. PRADHAN S, Lehman M, Tahir AM, Su M, et al
    Primary Cutaneous SMARCA4-Deficient Tumor With Metastases.
    J Cutan Pathol. 2025 Jun 4. doi: 10.1111/cup.14828.
    PubMed         Abstract available
    
    
39. NOLFF TM, Pedersen LD, Watts LYA, Klassen-Fischer MK, et al
    The Role of Gram Stain in Differentiating Superficial Cutaneous Fungal Organisms.
    J Cutan Pathol. 2025 Jun 4. doi: 10.1111/cup.14827.
    PubMed        
    
    
40. PALLA S, Bhatia P, Kumar N, Chatterjee D, et al
    Skin Biopsy Revealing Langerhans Cell Histiocytosis During Therapy for T-Cell Acute Lymphoblastic Leukemia: A Fatal Outcome.
    J Cutan Pathol. 2025 Jun 5. doi: 10.1111/cup.14831.
    PubMed        
    
    
41. MENDOZA CAC, Arana I, Cassarino DS
    Rare Concomitant Langerhans Cell Histiocytosis in a Patient With Folliculotropic Mycosis Fungoides.
    J Cutan Pathol. 2025;52:474-477.
    PubMed         Abstract available
    
    
42. ZENGIN S, Morehead LC, Shalin SC
    Histopathologic Features in Urticaria and Urticarial Variants: Plasma Cells Should Be Rare.
    J Cutan Pathol. 2025;52:497-505.
    PubMed         Abstract available
    
    
43. ARIOKA K, Sugawara T, Sasaki K, Funahashi M, et al
    Fibrofolliculoma/Trichodiscoma With Focal Follicular Germinative Cell Differentiation.
    J Cutan Pathol. 2025;52:478-481.
    PubMed         Abstract available
    
    
44. HOOTEN NK, Phelan PS, Shalin SC, Evans MS, et al
    Unilateral Pachydermodactyly in a Young Female: A Rare Diagnosis Requiring Novel Clinicopathological Correlation.
    J Cutan Pathol. 2025;52:453-458.
    PubMed         Abstract available
    
    

    
    J Dermatol

45. SHIBA M, Hagino T, Saeki H, Fujimoto E, et al
    The Sustainability of Week 16 Responses to Deucravacitinib Treatment for Patients With Psoriasis.
    J Dermatol. 2025 Jun 2. doi: 10.1111/1346-8138.17812.
    PubMed        
    
    
46. SUGAI S, Takamura S, Fukuda T
    Effect of IL-23p19 Inhibitors for Psoriasis With Bullous Pemphigoid: Clinical Insights From Two Cases.
    J Dermatol. 2025 May 30. doi: 10.1111/1346-8138.17805.
    PubMed        
    
    

    
    J Invest Dermatol

47. KIM JY, Lee EJ, Jang G, Park S, et al
    Targeting IL-24 signaling to restore skin barrier function: Discovery of penta-O-galloyl-beta-D-glucose via in silico screening.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00537.
    PubMed        
    
    
48. OCHIAI S, Larson AR, Mayer JU, Yang J, et al
    Allergic Skin Inflammation Drives IL-4-Dependent Differentiation of Dermal CD11b-low Dendritic Cells.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00536.
    PubMed         Abstract available
    
    
49. DUZ T, Torocsik D, Simmering A, Wolf P, et al
    High-Resolution Spatial Map of the Human Facial Sebaceous Gland Reveals Marker Genes and Decodes Sebocyte Differentiation.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00540.
    PubMed         Abstract available
    
    
50. HIERMAIER M, Egu DT, Sigmund AM, Ernst N, et al
    The Multi-kinase Inhibitor Midostaurin Mitigates Loss of Intercellular Adhesion and Skin Blistering in Pemphigus Vulgaris.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00538.
    PubMed         Abstract available
    
    
51. KENTLEY J, Kurtansky N, Jain M, Cordova M, et al
    Non-invasive diagnosis of melanoma using machine learning and reflectance confocal microscopy.
    J Invest Dermatol. 2025 May 29:S0022-202X(25)00539.
    PubMed        
    
    
52. MANN C, Ojak G, Hyde I, Beczinski J, et al
    Epidermal IL-36 and CCL17 protein expression distinguish palmar eczema from palmar psoriasis.
    J Invest Dermatol. 2025 May 30:S0022-202X(25)00535.
    PubMed        
    
    

    
    Lancet

53. GILBERT FJ, Payne NR, Allajbeu I, Yit L, et al
    Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trial.
    Lancet. 2025 May 21:S0140-6736(25)00582-3. doi: 10.1016/S0140-6736(25)00582.
    PubMed         Abstract available
    
    

    
    Mycoses

54. SHAO J, Xu J, Geng Y, Song Y, et al
    Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis.
    Mycoses. 2025;68:e70066.
    PubMed         Abstract available
    
    
55. LI L, Li J, Liu Z, Xia X, et al
    The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment.
    Mycoses. 2025;68:e70072.
    PubMed         Abstract available
    
    

    
    N Engl J Med

56. RISCHIN D, Porceddu S, Day F, Brungs DP, et al
    Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma.
    N Engl J Med. 2025 May 31. doi: 10.1056/NEJMoa2502449.
    PubMed         Abstract available
    
    
57. MAMOUNAS EP, Bandos H, White JR, Julian TB, et al
    Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy.
    N Engl J Med. 2025;392:2113-2124.
    PubMed         Abstract available
    
    

    
    PLoS One

58. TAYLOR C, Barry GJ, O'Neill DG, Guillen A, et al
    Survival time and prognostic factors in dogs clinically diagnosed with haemangiosarcoma in UK first opinion practice.
    PLoS One. 2025;20:e0316066.
    PubMed         Abstract available
    
    
59. WANG C, Zhang Y, Yang H, Zhou L, et al
    Platelet lysate-sodium hyaluronate gel promotes diabetic foot wound healing by regulating oxidative stress and autophagy.
    PLoS One. 2025;20:e0324264.
    PubMed         Abstract available
    
    
60. RIOKI JN, Mweu M, Rogena E, Songok EM, et al
    Factors associated with breast lesions among women attending select teaching and referral health facilities in Kenya: A cross-sectional study.
    PLoS One. 2025;20:e0309182.
    PubMed         Abstract available
    
    
61. YOOK HJ, Kim E, Kim YH, Lee GN, et al
    A link between smoking behaviors and the risk of hidradenitis suppurativa in diabetic patients.
    PLoS One. 2025;20:e0325357.
    PubMed         Abstract available
    
    
62. MARGULIES BS, Likhitpanichkul M, Tripathy D
    Reshaping the landscape of locoregional treatments for breast cancer liver metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells in the liver.
    PLoS One. 2025;20:e0323621.
    PubMed         Abstract available
    
    
63. WELLER SC, Pappadis MR, Krishnan S, Stearnes MR, et al
    Understanding motivations of older women to continue or discontinue breast cancer screening.
    PLoS One. 2025;20:e0319141.
    PubMed         Abstract available
    
    
64. ISSA E, Lahoud R, Abi-Gerges A, Salameh P, et al
    Breast cancer screening practices during a multifaceted crisis: Data from Lebanon.
    PLoS One. 2025;20:e0325604.
    PubMed         Abstract available
    
    
65. LOGANATHAN T, Doss C GP
    Gut microbiota and its influence on the Gut-Brain axis in comparison with chemotherapy patients and cancer-free control data in Breast cancer-A computational perspective.
    PLoS One. 2025;20:e0324742.
    PubMed         Abstract available
    
    
66. WANG T, Zang B, Kong C, Li Y, et al
    Intelligent and precise auxiliary diagnosis of breast tumors using deep learning and radiomics.
    PLoS One. 2025;20:e0320732.
    PubMed         Abstract available
    
    
67. LAI X, Yang Y, Zhang H, Zhang C, et al
    Bulk and single-cell RNA-sequencing analyses revealed potential key genes and the role of CCL19/CCL21-CCR7 axis in hidradenitis suppurativa.
    PLoS One. 2025;20:e0322565.
    PubMed         Abstract available
    
    
68. THAPAR P, Rakhra M, Prashar D, Mrsic L, et al
    Skin cancer segmentation and classification by implementing a hybrid FrCN-(U-NeT) technique with machine learning.
    PLoS One. 2025;20:e0322659.
    PubMed         Abstract available
    
    
69. WU G, Liu H, Wang M, Wang R, et al
    Identification of potential biomarkers associated with immune cell infiltration patterns in Kawasaki disease via bioinformatics.
    PLoS One. 2025;20:e0324337.
    PubMed         Abstract available
    
    
70. POPIC D, Marinovich ML, Houssami N, Hall J, et al
    How should artificial intelligence be used in breast screening? Women's reasoning about workflow options.
    PLoS One. 2025;20:e0323528.
    PubMed         Abstract available
    
    
71. MEHEDI MHK, Nafis KFZ, Charu KH, Uddin J, et al
    ArsenicNet: An efficient way of arsenic skin disease detection using enriched fusion Xception model.
    PLoS One. 2025;20:e0322405.
    PubMed         Abstract available
    
    
72. MERILAINEN AS, Sihto H, Isola J, Koljonen V, et al
    Clinicopathological comparison of eccrine poroma and porocarcinoma: Ki-67 index is not a decisive factor.
    PLoS One. 2025;20:e0324975.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.